Detalhe da pesquisa
1.
Nivolumab Combination Therapy in Advanced Esophageal Squamous-Cell Carcinoma.
N Engl J Med
; 386(5): 449-462, 2022 02 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35108470
2.
Atezolizumab plus modified docetaxel, cisplatin, and fluorouracil as first-line treatment for advanced anal cancer (SCARCE C17-02 PRODIGE 60): a randomised, non-comparative, phase 2 study.
Lancet Oncol
; 25(4): 518-528, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38547895
3.
T cell-inflamed gene expression profile and PD-L1 expression and pembrolizumab efficacy in advanced esophageal cancer.
Future Oncol
; 2022 Jul 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-35852104
4.
FOLFIRINOX De-Escalation in Advanced Pancreatic Cancer: A Multicenter Real-Life Study.
Oncologist
; 25(11): e1701-e1710, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32886823
5.
Atezolizumab plus modified docetaxel-cisplatin-5-fluorouracil (mDCF) regimen versus mDCF in patients with metastatic or unresectable locally advanced recurrent anal squamous cell carcinoma: a randomized, non-comparative phase II SCARCE GERCOR trial.
BMC Cancer
; 20(1): 352, 2020 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-32334548
6.
Docetaxel, cisplatin, and fluorouracil chemotherapy for metastatic or unresectable locally recurrent anal squamous cell carcinoma (Epitopes-HPV02): a multicentre, single-arm, phase 2 study.
Lancet Oncol
; 19(8): 1094-1106, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30042063
7.
Docetaxel, Cisplatin, and 5-fluorouracil (DCF) chemotherapy in the treatment of metastatic or unresectable locally recurrent anal squamous cell carcinoma: a phase II study of French interdisciplinary GERCOR and FFCD groups (Epitopes-HPV02 study).
BMC Cancer
; 17(1): 574, 2017 Aug 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-28841909
8.
First-Line Chemotherapy for Metastatic Esophageal Squamous Cell Carcinoma: Clinico-Biological Predictors of Disease Control.
Oncology
; 90(2): 88-96, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26784946
9.
Preoperative chemoradiation with paclitaxel-carboplatin or with fluorouracil-oxaliplatin-folinic acid (FOLFOX) for resectable esophageal and junctional cancer: the PROTECT-1402, randomized phase 2 trial.
BMC Cancer
; 16: 318, 2016 05 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-27194176
10.
Nivolumab plus chemotherapy or ipilimumab versus chemotherapy in patients with advanced esophageal squamous cell carcinoma (CheckMate 648): 29-month follow-up from a randomized, open-label, phase III trial.
Cancer Med
; 13(9): e7235, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38716626
11.
FOLFIRI Plus Durvalumab With or Without Tremelimumab in Second-Line Treatment of Advanced Gastric or Gastroesophageal Junction Adenocarcinoma: The PRODIGE 59-FFCD 1707-DURIGAST Randomized Clinical Trial.
JAMA Oncol
; 2024 Apr 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38573643
12.
Safety of FOLFIRI + Durvalumab +/- Tremelimumab in Second Line of Patients with Advanced Gastric Cancer: A Safety Run-In from the Randomized Phase II Study DURIGAST PRODIGE 59.
Biomedicines
; 10(5)2022 May 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-35625947
13.
Second-line treatment after docetaxel, cisplatin and 5-fluorouracil in metastatic squamous cell carcinomas of the anus. Pooled analysis of prospective Epitopes-HPV01 and Epitopes-HPV02 studies.
Eur J Cancer
; 162: 138-147, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34995900
14.
PD-1 Blockade in Solid Tumors with Defects in Polymerase Epsilon.
Cancer Discov
; 12(6): 1435-1448, 2022 06 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35398880
15.
Delayed anastomotic leakage following bevacizumab administration in colorectal cancer patients.
Acta Oncol
; 55(9-10): 1250-1252, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27172832
16.
FOLFIRINOX relative dose intensity and disease control in advanced pancreatic adenocarcinoma.
Ther Adv Med Oncol
; 13: 17588359211029825, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34349842
17.
Avelumab versus standard second line treatment chemotherapy in metastatic colorectal cancer patients with microsatellite instability: The SAMCO-PRODIGE 54 randomised phase II trial.
Dig Liver Dis
; 53(3): 318-323, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33359404
18.
Feasibility of liver transient elastography with FibroScan using a new probe for obese patients.
Liver Int
; 30(7): 1043-8, 2010 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-20492500
19.
Erythrocyte-encapsulated asparaginase (eryaspase) combined with chemotherapy in second-line treatment of advanced pancreatic cancer: An open-label, randomized Phase IIb trial.
Eur J Cancer
; 124: 91-101, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31760314
20.
Pooled analysis of 115 patients from updated data of Epitopes-HPV01 and Epitopes-HPV02 studies in first-line advanced anal squamous cell carcinoma.
Ther Adv Med Oncol
; 12: 1758835920975356, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33329760